Biomarkers in Type 2 diabetes: improving risk stratification with the PreDx ® Diabetes Risk Score.
about
New tools for weight-loss therapy enable a more robust medical model for obesity treatment: rationale for a complications-centric approachComprehensive biomarker testing of glycemia, insulin resistance, and beta cell function has greater sensitivity to detect diabetes risk than fasting glucose and HbA1c and is associated with improved glycemic control in clinical practiceIdentifying module biomarker in type 2 diabetes mellitus by discriminative area of functional activity.Serum α-hydroxybutyrate (α-HB) predicts elevated 1 h glucose levels and early-phase β-cell dysfunction during OGTT.Progression from impaired fasting glucose to type 2 diabetes mellitus among Chinese subjects with and without hypertension in a primary care setting.
P2860
Biomarkers in Type 2 diabetes: improving risk stratification with the PreDx ® Diabetes Risk Score.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Biomarkers in Type 2 diabetes: ...... e PreDx ® Diabetes Risk Score.
@en
Biomarkers in Type 2 diabetes: ...... e PreDx ® Diabetes Risk Score.
@nl
type
label
Biomarkers in Type 2 diabetes: ...... e PreDx ® Diabetes Risk Score.
@en
Biomarkers in Type 2 diabetes: ...... e PreDx ® Diabetes Risk Score.
@nl
prefLabel
Biomarkers in Type 2 diabetes: ...... e PreDx ® Diabetes Risk Score.
@en
Biomarkers in Type 2 diabetes: ...... e PreDx ® Diabetes Risk Score.
@nl
P2093
P2860
P356
P1476
Biomarkers in Type 2 diabetes: ...... e PreDx ® Diabetes Risk Score.
@en
P2093
Janice A Kolberg
Linda J Wuestehube
Mickey Urdea
Robert W Gerwien
Steve M Watkins
P2860
P304
P356
10.1586/ERM.11.63
P577
2011-11-01T00:00:00Z